These 2 ASX shares are buy-rated by many analysts

Australian Finance Group is one of the ASX shares that are buy-rated.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a few ASX shares where a number of analysts all believe that the business is good value.

Brokers are always on the lookout for opportunities. With share prices changing every day and every week, it can lead to some companies becoming opportunities as valuations change.

Whilst it's possible that all of those analysts are wrong at the same time, it could indicate that there is an opportunity:

ASX shares upgrade buy Woman in glasses writing on buy on board

Image Source: Getty Images

Australian Finance Group Ltd (ASX: AFG)

Australian Finance is one of the biggest mortgage brokers in the country.

It's currently rated as a buy by at least three brokers, including Macquarie Group Ltd (ASX: MQG). The broker has a price target of $3.18 on the business. That suggests that the Australian Finance Group share price could rise by almost 20% over the next 12 months, if the broker is right.

Macquarie noted the recently quarterly update by the ASX share for the first three months of FY22. The broker believes that Australian Finance Group's update showed good signs for its profit.

AFG said that mortgage brokers have lodged a record $24.1 billion in home loan finance for the first three months of the new financial year. That's almost $6 billion more than the same period last year. It was a 33% increase year on year and a 7% increase quarter on quarter.

However, the company noted that recent moves by the regulator to rein in the property market will affect borrowing capacity for some homebuyers.

Macquarie thinks that the current Australian Finance Group share price is valued at 14x FY22's estimated earnings with a grossed-up dividend yield of 7.5%.

Baby Bunting Group Ltd (ASX: BBN)

Baby Bunting is one of the leading retailers of baby products in Australia. It is also making moves to expand into New Zealand.

It's currently rated as a buy by at least five brokers, including Morgan Stanley, which has a price target of $6.90 on the business. The broker noted various positives from a recent trading update.

Baby Bunting said at its annual general meeting (AGM) that in the year to date, to 3 October, comparable store sales were strengthening and were only down 1.3%. In the first seven weeks of FY22, comparative sales had been down by 6.4%.

Excluding NSW and ACT stores, comparable store sales grew by 4.7% to early October.

Online sales (including click and collect) were up 37.7% by the ASX share, which was on top of 126% growth in the prior corresponding period.

The gross profit margin increased by another 120 basis points to 38.7%.

It's expecting to open between six to eight new stores in Australia in FY22, and two in New Zealand, towards the end of the second half of FY22.

Finally, the company said that the transformation program is "progressing well" with an anticipated launch of its new Australian website and phase two of the loyalty program in early November.

Using the projections by Morgan Stanley, the Baby Bunting share price is valued at 26x FY22's estimated earnings. It also comes with a projected FY22 grossed-up dividend yield of 3.8%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Baby Bunting. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A young well-dressed couple at a luxury resort celebrate successful life choices.
Growth Shares

5 great value ASX growth shares I'd buy and hold

These five ASX growth shares are trading well below recent highs, which could create opportunities for long-term investors.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes, symbolising dividends.
Growth Shares

The best ASX shares to invest $1,000 in right now

Analysts think these shares could be worth considering for an investment.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These valuations are too good to ignore! I'd buy these ASX shares today

I think these businesses have very attractive futures.

Read more »

A man and woman jump in the air and high five with both hands on a road after running.
Growth Shares

2 battered ASX growth shares that could double in value or more

Brokers are strikingly bullish and tip up to 180% upside.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 top ASX shares I'd buy right now in this March madness

The valuations these businesses are now trading at are too good to ignore!

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

3 undervalued ASX stocks to consider buying immediately

Analysts are tipping huge upsides ahead for these undervalued shares.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »